This position paper presents facts and figures regarding the evolution of interactions between pharma companies and physicians, and makes practical recommendations to ensure regular and impactful interactions in the years to come
News
This new position paper highlights the role of Voluntary Trade Organizations (VTOs) in the French retail drug...
We are pleased to offer you this new position paper, which highlights our latest analyses regarding the...
While the examination of the PLFSS 2025 is underway in Parliament, and the Leem (French Pharmaceutical Professional...